pharmaphorum
APRIL 26, 2021
Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. The goal of the partnership for approval for the Japanese market from the Pharmaceuticals and Medical Devices Agency (PMDA). Jolly Good has already won a “Home Healthcare Award” in a programme held by Teijin in December last year.
Druggist
APRIL 29, 2021
Apixaban (Eliquis®) and warfarin are two popular prescription-only drugs classified as anticoagulants, commonly known as blood thinners. Warfarin has been used as an anticoagulant for a very long time. However, in recent years warfarin’s popularity decreased in place of newer anticoagulants such as apixaban, as reflected by prescribing statistics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
APRIL 28, 2021
Introducing the recipient of the 2020-21 HBA Honorable Mentor Award, Dr. Rod MacKenzie , Chief Development Officer and EVP, Pfizer and the recipient of the 2020-21 HBA STAR Award, Susan Torroella , Chief Operating Officer, ArmadaHealth. What is the Honorable Mentor Award? The Honorable Mentor award recognizes a man who demonstrates a long-term commitment to advancing women in the workforce, is dedicated to developing, mentoring and promoting women in the industry, and is supportive of the overal
Outsourcing Pharma
APRIL 26, 2021
Published by Tabula Rasa Healthcare, the report looks at the MedWise Risk Score, technology designed to determine ADE risk rising from medication regimens.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
APRIL 30, 2021
Reports of COVID-19 vaccinations causing blood clots has caused alarm in the general population. However due to the rarity of incidences from vaccination, myGP explores the most common causes of blood clots and how we can prevent them. Over 11 million doses of COVID-19 vaccines have been given across the UK, with blood clotting observed in a small sample of patients.
Pharma Mirror
APRIL 28, 2021
Ahead of CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – the CPhI executive post-pandemic pharma survey[i] predicts that pandemic supply chain issues have further cemented a push for repatriated manufacturing globally. The findings suggest that over the next five years, governments and companies will gradually look to reduce complexity and increase regional self-reliance.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Outsourcing Pharma
APRIL 28, 2021
The combination of companies brings together ERTâs clinical endpoint data capabilities and Bioclinicaâs imaging, eClinical and drug-safety solutions.
pharmaphorum
APRIL 28, 2021
Today, most drug discovery programmes begin with the identification and validation of disease modifying biological targets. The primary way to uncover these targets is through searching and reviewing published scientific literature. Eric Gilbert explores how data science techniques like text mining are speeding up research into areas such as pancreatic cancer.
Pharma Mirror
APRIL 28, 2021
AavantiBio, a gene therapy company focused on transforming the lives of patients with rare genetic diseases, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced a partnership to support the development and manufacturing of AavantiBio’s gene therapies, including its lead program in Friedreich’s Ataxia (FA).
Pharma Marketing Network
APRIL 27, 2021
HBA Honorable Mentor 2020-21, Dr. Rod MacKenzie. Rod MacKenzie, PhD, is Chief Development Officer and Executive Vice President for Pfizer. Rod leads the Global Product Development organization, which is responsible for the clinical development and advancement of Pfizer’s pipeline of innovative medicines in inflammation and immunology, internal medicine, hospital, oncology and rare disease, as well as regulatory affairs in support of Pfizer’s R&D pipeline and portfolio of marketed therapies.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Outsourcing Pharma
APRIL 26, 2021
The chairman, president and CEO of Thermo Fisher says the acquisition stands to benefit clinical trial and drug development clients in a long list of ways.
pharmaphorum
APRIL 27, 2021
Cognoa has filed for FDA approval of a digital device that could be used to diagnose autism, which the company argues could redefine care standards. . Autism can be difficult to diagnose as there are no medical markers to show its presence – instead doctors look at the child’s developmental history and behaviour to make a diagnosis. Cognoa hopes to change this with an efficient and accurate approach that could allow diagnosis in primary care that won’t require a lengthy referral to a specialist.
Pharma Mirror
APRIL 28, 2021
Tokyo 27th April 2021: CPhI Japan, the first large pharma event to trade in 2021, played host to 7214 attendees at the exhibition and a further 7204 virtual users from across the globe. The event, a key marker for the strength of the regional industry, has rebounded quickly with some 216 exhibitors searching for pharma partners. In fact, such has been the demand, CPhI Japan Connect – the event’s digital platform for international audiences – will remain open until the end of May.
Pharma Marketing Network
APRIL 27, 2021
HBA STAR 2020-21, Susan Torroella. The 2020-2021 HBA STAR is Susan Torroella, President and CEO of ArmadaHealth, the leader in physician recommendation intelligence provided to employers through its QualityCare Connect? solution. For more than twenty years, Susan has been a dedicated HBA volunteer serving on the global board of directors, including as President of the Global Board in 2010.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
APRIL 29, 2021
In this first part of a series on the state of clinical research, an expert shares insightful ideas on how to improve patient experience and study results.
pharmaphorum
APRIL 27, 2021
Protracted diagnostic odysseys don’t only block access to rare disease treatments, they also leave people facing emotional turmoil all alone. Growing up in Glasgow, Linsey Brady “felt like a freak” and did everything she could to hide what she was told was a vascular deformation on her leg from the rest of the world. She was in her late 20s when, after years of struggling with her mental health and self-medicating with alcohol, she was finally diagnosed with Klippel Trenaunay Syndrome (KTS).
Pharma Mirror
APRIL 27, 2021
Scivita Medical Technology Co., Ltd. (“Scivita Medical”) announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become one of the highest financing projects in the field of endoscope in China in recent years. The investment was jointly led by GL Ventures and Lilly Asia Ventures, with contribution from Matrix Partners China, Medtronic, Chengwei Capital and Shanghai Innochip Investment.
Pharma Marketing Network
APRIL 29, 2021
[link]. The post DarshanTalks: How Are Your Candidates #jobhacking?</br>– April 29, 2021 appeared first on Pharma Marketing Network.
Outsourcing Pharma
APRIL 29, 2021
New preclinical research, published in Nature, suggests a new avenue for Alzheimerâs disease (AD) treatment, through restoring lymphatic flow in the brain.
pharmaphorum
APRIL 30, 2021
Indivior has paid out $300 million to resolve civil claims from US states after it was last year found guilty against criminal charges of improper marketing of the opioid addiction drug Suboxone. Last year, Indivior reached a $600 million settlement plea deal to settle criminal fraud charges, after US authorities found the company’s conduct had results in improper use of state Medicaid funds.
Med Ed 101
APRIL 28, 2021
Chemotherapeutic agents are used to control cancer cell proliferation, but they often come with toxicities to the host as well. It is important to monitor patients closely for the development of toxicities during therapy. Some of the potential toxicities of common chemotherapeutics are outlined below in our Chemotherapy Toxicity Table. Myelosuppression is a common adverse […].
Pharma Times
APRIL 29, 2021
The 2021 Marketer of the Year competition is well underway for entries and is looking for the best and brightest to join the ranks.
Outsourcing Pharma
APRIL 29, 2021
A leader from the CRO talks about increased use of electronic patient-reported outcomes in research, challenges of adoption, and how ePRO benefits trials.
pharmaphorum
APRIL 30, 2021
It’s fair to say this is the most interesting time ever for market access. Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks. We take a look at all these intersecting topics in this issue – with experts from across the industry sharing their advice on how companies can navigate thes
Med Ed 101
APRIL 25, 2021
We received a big update on 2021 Pharmacist Provider Status this month and it is exciting to see that we still on the radar of the federal government. I have just emailed my representative this morning and am asking you to do the same. Pharmacist provider status will not happen without action. I will be placing […]. The post 2021 Pharmacist Provider Status Update appeared first on Med Ed 101.
Pharma Times
APRIL 27, 2021
Medicine recommended for the treatment of visual impairment in Leber’s Hereditary Optic Neuropathy
Outsourcing Pharma
APRIL 29, 2021
In this first part of a series on the state of clinical research, an expert shares insightful ideas on how to improve patient experience and study results.
pharmaphorum
APRIL 29, 2021
The UK has ordered an extra 60 million doses of the Pfizer/BioNTech COVID-19 vaccine, which could be used as a potential booster campaign in the autumn. Health secretary Matt Hancock made the announcement in a press briefing, revealing that officials think they may have to boost protection for the population during the winter. The UK looks on course to lift all coronavirus restrictions by 21st June, following a further easing of regulations in mid-May.
Pharma Marketing Network
APRIL 30, 2021
Clinical trials may be one of the very last bastions of a non-customer-focused approach within the pharmaceutical industry. Protocols, which have remained substantively unchanged for over 30 years, often impose an immense burden on patient participants, largely due to the frequency of site visits. Across the board, from rheumatology to neurology, outcomes that matter most to patients, have traditionally not been captured in clinical trials.
Pharma Times
APRIL 26, 2021
Monoclonal antibody reduced lower respiratory tract infections due to RSV in healthy infants
Outsourcing Pharma
APRIL 29, 2021
In this first part of a series on the state of clinical research, an expert shares insightful ideas on how to improve patient experience and study results.
pharmaphorum
APRIL 30, 2021
AstraZeneca’s not-for-profit coronavirus vaccine has bit into margins in Q1, although revenues were ahead of expectations as the company heads towards completion of its $39bn acquisition of Alexion. . The company posted Q1 product sales of $7.26bn, ahead of consensus forecasts of around $6.84 billion, with total revenues up 15% compared with last year’s Q1 to $7.3bn.
pharmaphorum
APRIL 29, 2021
GlaxoSmithKline’s CEO Emma Walmsley said the company is focused on pursuing its strategy to spin off its consumer business after downbeat set of first quarter results. Pharma sales were down 12% compared with last year’s Q1 to £3.9 billion and its vaccines business has also been hit by a 32% slump as people put off getting vaccinated against shingles with its lead product Shingrix during the pandemic.
pharmaphorum
APRIL 29, 2021
Calliditas Therapeutics could have its first product on the market in the US this autumn, as the FDA has now started a priority review of Nefecon for rare disease primary IgA nephropathy (IgAN). . The Swedish biotech says the IUS regulator has set an action date of 15 September for its review of Nefecon, a novel formulation of the established corticosteroid drug budesonide that could become the first ever approved therapy for IgAN.
Expert insights. Personalized for you.
122 
Let's personalize your content